Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.

"The authors have declared no conflicts of interest."

"Contract/grant details: The research was funded by Skeletal Cancer Action Trust (SCAT), UK. Support was provided to by the National Institute for Health Research, UCLH Biomedical Research Centre (AMF), and the National Institute for Health Research, Musculoskeletal BRU Oxford Sarcoma Theme, and the CRUK UCL Experimental Medicine Cancer Centre (AMF), and the EuroBoNeT consortium, a European Commission granted Network of Excellence for studying the pathology and genetics of bone tumours. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). SB is funded through the Wellcome Trust PhD Programme for Clinicians. DB and GJ were supported by the Foundation for the Preservation of the Basel Bone Tumor Reference Center."